GeneVentiv Therapeutics, Inc. — Form D

GeneVentiv Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-17. The offering totals $2.0M, of which $1.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-08-17
• Form: D
• Accession: 0001942327-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $1.4M
• Remaining: $600K
• Investors: 1
• Date of first sale: 2022-07-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-456181

Issuer

• Name: GeneVentiv Therapeutics, Inc.
• CIK: 0001942327
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 150 FAYETTEVILLE STREET, RALEIGH, NC, 27601
• Phone: 919-529-3352

Officers, directors & promoters (3)

More

• CIK 1942327 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search